C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/86 (2006.01) A61K 38/16 (2006.01) A61K 48/00 (2006.01) C12N 5/10 (2006.01) C12N 15/34 (2006.01) C12N 15/38 (2006.01)
Patent
CA 2318664
This invention suppresses the immune response to viral or non-viral based methods of gene delivery by incorporating immunosuppressive genes within the gene delivery system. These immunosuppressive genes may be used in addition to a therapeutic treatment or as a therapeutic treatment by themselves.
La présente invention concerne un procédé permettant la suppression de la réponse immunitaire en cas d'introduction de gènes selon des techniques de type virales ou non virales. A cet effet, on incorpore des gènes d'immuno-dépression dans le système d'introduction des gènes. Ces gènes d'immuno-dépression peuvent s'utiliser en complément d'un traitement thérapeutique ou directement comme traitement thérapeutique.
Link Charles J. Jr.
Radosevich Thomas J.
Human Gene Therapy Research Institute
Ridout & Maybee Llp
LandOfFree
Nucleotide expression systems with reduced immunogenicity... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleotide expression systems with reduced immunogenicity..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleotide expression systems with reduced immunogenicity... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1598753